By contrast, in the PTCL-NOS subgroup of tumors, mutations in the RHOA gene were associated with IDH2 (p < 0.005) and PLCG1 (p = 0.008) gene mutations. This evidence concerns the gene IDH2 and mature T-cell and NK-cell non-Hodgkin lymphoma.